Publications

Discussions in the Microbiology Working Group regarding the timeliness associated with the testing for bioburden, dose establishment, and sterilization dose audits following the manufacture of healthcare products, has led to the following guidance document. The aim of this document is to assist both manufacturers and laboratories in following the relevant standards and to support their justifications for testing practises in audit situations.